|
1.Name of the securities:CHINA CHEMICAL & PHARMACEUTICAL CO., LTD.
2.Trading date:2021/01/20~2021/05/31
3.Amount, unit price, and total monetary amount of the transaction:
Trading volume: 6,805,000 shares;
Unit price: Average price NT$ 23.28per share;
Total monetary amount: NT$ 158,423,131(including related taxes
and expenses)
4.Gain (or loss) through disposal (not applicable in case of acquisition of
securities):NA
5.Relationship with the underlying company of the trade:
CCSB is the Company's investment using the equity method of accounting.
6.Current cumulative amount held, monetary amount, and shareholding
percentage of cumulative holdings of the securities being traded (including
the current trade), and status of any restriction of rights (e.g.pledges):
Current cumulative volume：32,099,137 shares
Amount：NT$622,064,453
Shareholding percentage of holdings of the security being traded
(including the current trade)：10.77 %
Status of any restriction of rights：None
7.Current ratio of securities investment (including the current trade, as
listed in article 3 of Regulations Governing the Acquisition and Disposal of
Assets by Public Companies) to the total assets and equity attributable to
owners of the parent as shown in the most recent financial statement and
working capital as shown in the most recent financial statement as of the
present:
Ratio to the total assets: 23.51%
Ratio to the shareholder's equity: 28.15 %
Operational capital: NT$ 589,717 thousand
8.Concrete purpose of the acquisition or disposal:Investment
9.Any dissenting opinions of directors to the present transaction:No
10.Whether the counterparty of the current transaction is a related party:No
11.Trading counterparty and its relationship with the Company:NA
12.Date of the board of directors resolution:2020/11/27
13.Date of ratification by supervisors or approval by
the audit committee:2020/11/27
14.Any other matters that need to be specified:None
|
